Literature DB >> 34678302

A Conservative Point Mutation in a Dynamic Antigen-binding Loop of Human Immunoglobulin λ6 Light Chain Promotes Pathologic Amyloid Formation.

Daniele Peterle1, Elena S Klimtchuk2, Thomas E Wales3, Florian Georgescauld4, Lawreen H Connors5, John R Engen6, Olga Gursky7.   

Abstract

Immunoglobulin light chain (LC) amyloidosis (AL) is a life-threatening human disease wherein free mono-clonal LCs deposit in vital organs. To determine what makes some LCs amyloidogenic, we explored patient-based amyloidogenic and non-amyloidogenic recombinant LCs from the λ6 subtype prevalent in AL. Hydrogen-deuterium exchange mass spectrometry, structural stability, proteolysis, and amyloid growth studies revealed that the antigen-binding CDR1 loop is the least protected part in the variable domain of λ6 LC, particularly in the AL variant. N32T substitution in CRD1 is identified as a driver of amyloid formation. Substitution N32T increased the amyloidogenic propensity of CDR1 loop, decreased its protection in the native structure, and accelerated amyloid growth in the context of other AL substitutions. The destabilizing effects of N32T propagated across the molecule increasing its dynamics in regions ∼30 Å away from the substitution site. Such striking long-range effects of a conservative point substitution in a dynamic surface loop may be relevant to Ig function. Comparison of patient-derived and engineered proteins showed that N32T interactions with other substitution sites must contribute to amyloidosis. The results suggest that CDR1 is critical in amyloid formation by other λ6 LCs.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CDR loops; hydrogen-deuterium exchange mass spectrometry; light chain amyloidosis; propagation of mutational effects; protein conformation

Mesh:

Substances:

Year:  2021        PMID: 34678302      PMCID: PMC8627465          DOI: 10.1016/j.jmb.2021.167310

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  48 in total

1.  Thermodynamic modulation of light chain amyloid fibril formation.

Authors:  Y Kim; J S Wall; J Meyer; C Murphy; T W Randolph; M C Manning; A Solomon; J F Carpenter
Journal:  J Biol Chem       Date:  2000-01-21       Impact factor: 5.157

Review 2.  Review: immunoglobulin light chain amyloidosis--the archetype of structural and pathogenic variability.

Authors:  V Bellotti; P Mangione; G Merlini
Journal:  J Struct Biol       Date:  2000-06       Impact factor: 2.867

3.  IMGT(®) tools for the nucleotide analysis of immunoglobulin (IG) and T cell receptor (TR) V-(D)-J repertoires, polymorphisms, and IG mutations: IMGT/V-QUEST and IMGT/HighV-QUEST for NGS.

Authors:  Eltaf Alamyar; Patrice Duroux; Marie-Paule Lefranc; Véronique Giudicelli
Journal:  Methods Mol Biol       Date:  2012

4.  Stabilization of amyloidogenic immunoglobulin light chains by small molecules.

Authors:  Gareth J Morgan; Nicholas L Yan; David E Mortenson; Enrico Rennella; Joshua M Blundon; Ryan M Gwin; Chung-Yon Lin; Robyn L Stanfield; Steven J Brown; Hugh Rosen; Timothy P Spicer; Virneliz Fernandez-Vega; Giampaolo Merlini; Lewis E Kay; Ian A Wilson; Jeffery W Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-10       Impact factor: 11.205

5.  Domain Interactions Determine the Amyloidogenicity of Antibody Light Chain Mutants.

Authors:  Benedikt Weber; Manuel Hora; Pamina Kazman; Tejaswini Pradhan; Florian Rührnößl; Bernd Reif; Johannes Buchner
Journal:  J Mol Biol       Date:  2020-10-13       Impact factor: 5.469

6.  Protease-sensitive regions in amyloid light chains: what a common pattern of fragmentation across organs suggests about aggregation.

Authors:  Giulia Mazzini; Stefano Ricagno; Serena Caminito; Paola Rognoni; Paolo Milani; Mario Nuvolone; Marco Basset; Andrea Foli; Rosaria Russo; Giampaolo Merlini; Giovanni Palladini; Francesca Lavatelli
Journal:  FEBS J       Date:  2021-09-15       Impact factor: 5.622

7.  Immunoglobulin light chain amyloidosis: 2020 update on diagnosis, prognosis, and treatment.

Authors:  Morie A Gertz
Journal:  Am J Hematol       Date:  2020-04-28       Impact factor: 10.047

Review 8.  Immunoglobulin free light chain dimers in human diseases.

Authors:  Batia Kaplan; Avi Livneh; Ben-Ami Sela
Journal:  ScientificWorldJournal       Date:  2011-03-22

9.  Cryo-EM structure of a light chain-derived amyloid fibril from a patient with systemic AL amyloidosis.

Authors:  Lynn Radamaker; Yin-Hsi Lin; Karthikeyan Annamalai; Stefanie Huhn; Ute Hegenbart; Stefan O Schönland; Günter Fritz; Matthias Schmidt; Marcus Fändrich
Journal:  Nat Commun       Date:  2019-03-20       Impact factor: 14.919

10.  The CDR1 and Other Regions of Immunoglobulin Light Chains are Hot Spots for Amyloid Aggregation.

Authors:  Robin Axel Ruiz-Zamora; Simon Guillaumé; Youssra K Al-Hilaly; Zahraa Al-Garawi; Francisco Javier Rodríguez-Alvarez; Guadalupe Zavala-Padilla; Julio I Pérez-Carreón; Sandra L Rodríguez-Ambriz; Guillermo A Herrera; Baltazar Becerril-Luján; Adrián Ochoa-Leyva; Jorge Melendez-Zajgla; Louise Serpell; Luis Del Pozo-Yauner
Journal:  Sci Rep       Date:  2019-02-28       Impact factor: 4.379

View more
  1 in total

1.  Simple and Fast Maximally Deuterated Control (maxD) Preparation for Hydrogen-Deuterium Exchange Mass Spectrometry Experiments.

Authors:  Daniele Peterle; Thomas E Wales; John R Engen
Journal:  Anal Chem       Date:  2022-07-07       Impact factor: 8.008

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.